Kar Andish Rahro Afarin (Karafarin Co.) participated as the sponsor of 14th International & 20th National Congress on Quality Improvement in Clinical Laboratories (QICL 2023), a leading national trade fair, which was held on 16-19 May, 2023 in Tehran. Karafarin Co. showcased the latest innovations of point-of-care diagnostic systems at the QICL 2023 alongside its whole team of administration. During the QICL 2023 exhibition, Karafarin Co. team shared their experiences with their clients and promoted the new generation of IVD technologies. Genrui Quantitative Immunoassay Analyzer FA50 (POCT), which is an easy-to-use fluorescent immunoassay system was demonstrating by marketing team alongside Mr. Lucas Zhu, Genrui’s Sales Manager (Middle East), who was the special guest of Karafarin Co. The other agenda during the QICL was to negotiate with world’s leading IVD companies to get new IVD representation for Iranian market. Supports from customers are always the driving force to encourage us to distribute higher quality products and services. With this faith, it is an honor to express that Karafarin Co. has been equipped its production facility to localize manufacturing of FA50 POCT reagents (cTnI, D-Dimer, HbA1c and AMH) to support its customers better than ever. Kar Andish Rahro Afarin (Karafarin Co.) will continue bringing innovative IVD products and bringing better services for everyone. Kar Andish Rahro Afarin (Karafarin Co.) will continue bringing innovative IVD solutions to provide “The Next-Generation of In-vitro diagnostic” to serve the health of our people.